We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+26.9%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$1.05B
AUM Growth
+$91.8M
Cap. Flow
-$24.1M
Cap. Flow %
-2.3%
Top 10 Hldgs %
32.3%
Holding
111
New
20
Increased
23
Reduced
56
Closed
11

Top Buys

Rank Stock Value
1
MASI
Masimo
MASI
+$28.6M
2
DXCM icon
DexCom
DXCM
+$26.9M
3
EYPT icon
EyePoint Inc
EYPT
+$15.4M
4
WAT icon
Waters Corp
WAT
+$15.4M
5
MTD icon
Mettler-Toledo International
MTD
+$15.3M

Top Sells

Rank Stock Value
1
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$17.7M
2
BIIB icon
Biogen
BIIB
+$15.5M
3
DHR icon
Danaher
DHR
+$11.4M
4
CSTL icon
Castle Biosciences
CSTL
+$10.5M
5
VRDN icon
Viridian Therapeutics
VRDN
+$10M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABVX
101
Abivax
ABVX
$10.9B
– –
-55,197
Closed -$4.69M
ASND icon
102
Ascendis Pharma A/S
ASND
$16.8B
– –
-40,343
Closed -$8.02M
BMRN icon
103
BioMarin Pharmaceuticals
BMRN
$13.6B
– –
-125,949
Closed -$6.82M
DVAX
104
DELISTED
Dynavax Technologies
DVAX
– –
-271,306
Closed -$2.69M
INCY icon
105
Incyte
INCY
$24.5B
– –
-100,442
Closed -$8.52M
LLY icon
106
Eli Lilly
LLY
$1.09T
– –
-10,000
Closed -$7.63M
MASS icon
107
908 Devices
MASS
$414M
– –
-100,368
Closed -$879K
OM icon
108
Outset Medical
OM
$84.6M
– –
-454,512
Closed -$6.42M
QQQ icon
109
PUT
Invesco QQQ Trust
QQQ
$481B
– –
-80,000
Closed -$48M
UTHR icon
110
United Therapeutics
UTHR
$21.9B
– –
-22,000
Closed -$9.22M
TVRD
111
Tvardi Therapeutics
TVRD
$22.1M
– –
-65,000
Closed -$2.53M
1 2 3 4
5

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Parkman Healthcare Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Parkman Healthcare Partners held 111 positions worth $1.05B, up 9.6% from $959M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Parkman Healthcare Partners's Q4 2025 filing shows 20 new, 23 increased, 56 reduced and 11 closed positions. Its largest new stake was Masimo: 200,000 shares worth $26M. The largest sale was Alnylam Pharmaceuticals, an estimated $17.7M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 95% a quarter earlier.

  • Parkman Healthcare Partners's largest Q4 2025 buy was Masimo: 200,000 shares worth $26M.
  • Parkman Healthcare Partners added most to DexCom in Q4 2025, an estimated $26.9M increase.
  • Parkman Healthcare Partners's biggest Q4 2025 reduction was Alnylam Pharmaceuticals, cutting an estimated $17.7M.
  • Parkman Healthcare Partners fully exited United Therapeutics in Q4 2025, selling an estimated $9.22M.
  • Parkman Healthcare Partners's ten largest holdings make up 32% of its $1.05B portfolio in Q4 2025.
  • Parkman Healthcare Partners opened 20 new positions and closed 11 in Q4 2025.
  • Parkman Healthcare Partners's portfolio value rose 9.6% quarter-over-quarter to $1.05B.

Based on Parkman Healthcare Partners's 13F filing for Q4 2025, filed 17 Feb 2026.